Suppr超能文献

糖尿病引起的细胞外基质改变及其对心肌功能的影响。

Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.

机构信息

Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, 6439 Garners Ferry Rd., Columbia, SC 29209, USA.

出版信息

Microsc Microanal. 2012 Feb;18(1):22-34. doi: 10.1017/S1431927611012256. Epub 2012 Jan 5.

Abstract

Diabetes is an increasing public health problem that is expected to escalate in the future due to the growing incidence of obesity in the western world. While this disease is well known for its devastating effects on the kidneys and vascular system, diabetic individuals can develop cardiac dysfunction, termed diabetic cardiomyopathy, in the absence of other cardiovascular risk factors such as hypertension or atherosclerosis. While much effort has gone into understanding the effects of elevated glucose or altered insulin sensitivity on cellular components within the heart, significant changes in the cardiac extracellular matrix (ECM) have also been noted. In this review article we highlight what is currently known regarding the effects diabetes has on both the expression and chemical modification of proteins within the ECM and how the fibrotic response often observed as a consequence of this disease can contribute to reduced cardiac function.

摘要

糖尿病是一个日益严重的公共卫生问题,由于西方世界肥胖症的发病率不断上升,预计未来这一问题还会进一步恶化。尽管这种疾病对肾脏和血管系统的破坏性影响众所周知,但在没有高血压或动脉粥样硬化等其他心血管危险因素的情况下,糖尿病患者也可能出现心脏功能障碍,即糖尿病心肌病。虽然人们已经投入大量精力来了解升高的葡萄糖或改变的胰岛素敏感性对心脏内细胞成分的影响,但也注意到心脏细胞外基质 (ECM) 发生了显著变化。在这篇综述文章中,我们重点介绍了糖尿病对 ECM 中蛋白质的表达和化学修饰的影响,以及这种疾病常导致的纤维化反应如何导致心脏功能降低。

相似文献

1
Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.
Microsc Microanal. 2012 Feb;18(1):22-34. doi: 10.1017/S1431927611012256. Epub 2012 Jan 5.
2
Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis.
J Mol Cell Cardiol. 2010 Mar;48(3):524-9. doi: 10.1016/j.yjmcc.2009.06.021. Epub 2009 Jul 9.
4
Diabetes-induced abnormalities in the myocardium.
Life Sci. 1986 Mar 17;38(11):959-74. doi: 10.1016/0024-3205(86)90229-8.
5
Syndecans in heart fibrosis.
Cell Tissue Res. 2016 Sep;365(3):539-52. doi: 10.1007/s00441-016-2454-2. Epub 2016 Jul 14.
6
The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy.
J Am Coll Cardiol. 2006 Feb 21;47(4):693-700. doi: 10.1016/j.jacc.2005.09.050. Epub 2006 Jan 26.
7
Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
Basic Res Cardiol. 2011 Nov;106(6):1023-39. doi: 10.1007/s00395-011-0228-2. Epub 2011 Oct 20.
8
Diabetic cardiomyopathy.
Am Heart J. 1989 Nov;118(5 Pt 1):1000-12. doi: 10.1016/0002-8703(89)90236-6.
9
Extracellular matrix remodeling and cardiac fibrosis.
Matrix Biol. 2018 Aug;68-69:490-506. doi: 10.1016/j.matbio.2018.01.013. Epub 2018 Jan 31.

引用本文的文献

2
Hidden pathway: the role of extracellular matrix in type 2 diabetes mellitus-related sarcopenia.
Front Endocrinol (Lausanne). 2025 Apr 16;16:1560396. doi: 10.3389/fendo.2025.1560396. eCollection 2025.
3
The molecular determinants regulating redox signaling in diabetic endothelial cells.
Front Pharmacol. 2025 Apr 1;16:1563047. doi: 10.3389/fphar.2025.1563047. eCollection 2025.
4
Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications.
Adv Drug Deliv Rev. 2024 Jun;209:115303. doi: 10.1016/j.addr.2024.115303. Epub 2024 Apr 6.
5
Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population.
Biomedicines. 2023 May 25;11(6):1523. doi: 10.3390/biomedicines11061523.
7
Combination of common mtDNA variants results in mitochondrial dysfunction and a connective tissue dysregulation.
Proc Natl Acad Sci U S A. 2022 Nov 8;119(45):e2212417119. doi: 10.1073/pnas.2212417119. Epub 2022 Nov 2.
8
The Diabetic Cardiorenal Nexus.
Int J Mol Sci. 2022 Jul 1;23(13):7351. doi: 10.3390/ijms23137351.
10
Linking Oxidative Stress and DNA Damage to Changes in the Expression of Extracellular Matrix Components.
Front Genet. 2021 Jul 29;12:673002. doi: 10.3389/fgene.2021.673002. eCollection 2021.

本文引用的文献

1
Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease.
Curr Opin Nephrol Hypertens. 2010 Nov;19(6):527-33. doi: 10.1097/MNH.0b013e32833e9259.
2
The origin of fibroblasts and mechanism of cardiac fibrosis.
J Cell Physiol. 2010 Nov;225(3):631-7. doi: 10.1002/jcp.22322.
4
Methylglyoxal-modified collagen promotes myofibroblast differentiation.
Matrix Biol. 2010 Jul;29(6):537-48. doi: 10.1016/j.matbio.2010.04.004. Epub 2010 Apr 25.
5
Diabetic cardiomyopathy, causes and effects.
Rev Endocr Metab Disord. 2010 Mar;11(1):31-9. doi: 10.1007/s11154-010-9131-7.
6
Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes.
Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2109-19. doi: 10.1152/ajpheart.00157.2009. Epub 2009 Oct 9.
7
Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium.
Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1147-53. doi: 10.1152/ajpendo.00327.2009. Epub 2009 Aug 25.
10
Cardiac fibroblasts: at the heart of myocardial remodeling.
Pharmacol Ther. 2009 Aug;123(2):255-78. doi: 10.1016/j.pharmthera.2009.05.002. Epub 2009 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验